定量噴霧式吸入器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の定量噴霧式吸入器の市場規模は、2023年に166億1,300万米ドル、2030年までに214億2,300万米ドルに達し、2024年～2030年の予測期間にCAGRで3.99％の成長が見込まれます。市場は、COVID-19の有病率の増加、糖尿病の有病率の増加、喘息の有病率の増加、嚢胞性線維症の症例の急増、慢性閉塞性肺疾患（COPD）の有病率の急増、老年人口の増加、製品の提供に関する技術の進歩の増加などのさまざまな要因によりプラス成長を示しています。したがって、定量噴霧式吸入器の市場は、2024年～2030年の予測期間に成長すると予測されます。

定量噴霧式吸入器の市場力学

糖尿病の有病率の増加は、定量噴霧式吸入器の市場の主な促進要因の1つです。例えば、国際糖尿病連合（IDF）の、2023年に発表されたIDF Diabetes Atlas Tenth editionによると、世界中で、20～79歳の約5億3,700万人が糖尿病に罹患していました。さらに、糖尿病は2030年までに世界で6億4,300万人、2045年までに7億8,300万人が罹患すると予測されています。さらに、インスリン粉末は糖尿病を治療するために定量噴霧式吸入器によって投与されます。その結果、糖尿病患者の増加により定量噴霧式吸入器に対する需要が高まり、予測期間（2024年～2030年）に世界の定量噴霧式吸入器市場を牽引します。

さらに、定量噴霧式吸入器市場の成長をもたらすもう1つの主な要因は、喘息の有病率の増加です。例えば、世界保健機関（WHO）が2023年に発表したデータによると、2019年、世界で推定2億6,200万人が喘息を患っています。さらに、Asthma and Allergy Foundation of Americaが2023年に発表したデータによると、2019年、米国では約2,500万人が喘息を患っていました。そのため、定量噴霧式吸入器が喘息の治療に使用されています。したがって、喘息における有病率の上昇は、定量噴霧式吸入器の需要を増加させ、予測期間（2024年～2030年）に定量噴霧式吸入器市場全体を前進させます。

しかし、定量噴霧式吸入器に関する認知の不足と機器に関連する深刻な副作用が、世界の定量噴霧式吸入器市場の成長を妨げる可能性があります。

COVID-19パンデミックは、定量噴霧式吸入器市場にプラスの影響を与えています。これは、COVID-19の肺への深刻な影響によるものであり、COVID-19の後遺症として呼吸器感染症に罹患する可能性があると推定され、COVID-19で回復した患者において定量噴霧式吸入器の需要が急増しました。従って、2024年～2030年の予測期間に、定量噴霧式吸入器の需要は増加し続ける見込みです。

定量噴霧式吸入器市場のセグメント分析

定量噴霧式吸入器市場の用途セグメントでは、慢性閉塞性肺疾患（COPD）が2023年に大きな収益を占めると予測されています。定量噴霧式吸入器は、喘息薬をエアロゾルの形で肺に供給する、携帯可能な使いやすいデバイスです。これらは、フロベントハイドロフルオロアルカン（HFA）を含むステロイドや、シムビコートなどのステロイド/気管支拡張薬の組み合わせ、複合薬などのさまざまなCOPD治療薬と使用できます。従って、定量噴霧式吸入器に関連するこれらの利点は、定量噴霧式吸入器の需要を増加させ、定量噴霧式吸入器市場全体を増大させる可能性があります。一方、定量噴霧式吸入器に関連する製品の発売の増加も、その市場成長を促進します。

2020年10月、多国籍製薬企業であるZydus Cadilaは、インドの慢性閉塞性肺疾患（COPD）患者向けに、長時間作用性ムスカリン拮抗薬（LAMA）と長時間作用性β作動薬（LABA）を組み合わせたインド初の加圧定量噴霧式吸入器（pMDI）であるForglyn pMDIの発売を発表しました。

当レポートでは、世界の定量噴霧式吸入器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 定量噴霧式吸入器市場レポートのイントロダクション

第2章 定量噴霧式吸入器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 定量噴霧式吸入器市場の主な要因の分析

• 定量噴霧式吸入器市場の促進要因
  • 糖尿病の有病率の増加
  • 喘息の有病率の上昇
  • 嚢胞性線維症の症例の急増
  • COVID-19の流行
• 定量噴霧式吸入器市場の抑制要因と課題
  • 定量噴霧式吸入器に関する認知の不足
  • 定量噴霧式吸入器に関連する重篤な副作用
• 定量噴霧式吸入器市場の機会
  • 定量噴霧式吸入器のスマート吸入器への変換
  • 定量噴霧式吸入器の研究開発活動の増加

第5章 定量噴霧式吸入器市場のポーターのファイブフォース分析

第6章 定量噴霧式吸入器市場に対するCOVID-19の影響の分析

第7章 定量噴霧式吸入器の市場レイアウト

• 患者タイプ別
  • 成人
  • 小児
• 用途別
  • 慢性閉塞性肺疾患（COPD）
  • 喘息
  • COVID-19
  • 糖尿病
  • 嚢胞性線維症
  • その他
• 流通チャネル別
  • オンライン
  • オフライン
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 定量噴霧式吸入器市場の企業と製品のプロファイル

• H&T Presspart Manufacturing Ltd
• MidasCare
• Beximco Pharmaceuticals Ltd
• BioCare Group (M) Sdn Bhd
• Intech Biopharm Corporation
• AstraZeneca
• Recipharm AB (publ)
• Maya Biotech Pvt. Ltd
• BreatheSuite Inc

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Metered Dose Inhaler Devices market in Global (2021-2030)
• Table 4: Metered Dose Inhaler Devices market in Global by Patient Type (2021-2030)
• Table 5: Metered Dose Inhaler Devices market in Global by Application (2021-2030)
• Table 6: Metered Dose Inhaler Devices market in Global by Distribution Channel (2021-2030)
• Table 7: Metered Dose Inhaler Devices market in Global by Geography (2021-2030)
• Table 8: Metered Dose Inhaler Devices market in North America (2021-2030)
• Table 9: Metered Dose Inhaler Devices market in North America by Country (2021-2030)
• Table 10: Metered Dose Inhaler Devices market in the US (2021-2030)
• Table 11: Metered Dose Inhaler Devices market in Canada (2021-2030)
• Table 12: Metered Dose Inhaler Devices market in Mexico (2021-2030)
• Table 13: Metered Dose Inhaler Devices market in Europe (2021-2030)
• Table 14: Metered Dose Inhaler Devices market in Europe by Country (2021-2030)
• Table 15: Metered Dose Inhaler Devices market in France (2021-2030)
• Table 16: Metered Dose Inhaler Devices market in Germany (2021-2030)
• Table 17: Metered Dose Inhaler Devices market in the United Kingdom (2021-2030)
• Table 18: Metered Dose Inhaler Devices market in Italy (2021-2030)
• Table 19: Metered Dose Inhaler Devices market in Spain (2021-2030)
• Table 20: Metered Dose Inhaler Devices market in Russia (2021-2030)
• Table 21: Metered Dose Inhaler Devices market in Rest of Europe (2021-2030)
• Table 22: Metered Dose Inhaler Devices market in APAC (2021-2030)
• Table 23: Metered Dose Inhaler Devices market in APAC by Country (2021-2030)
• Table 24: Metered Dose Inhaler Devices market in China (2021-2030)
• Table 25: Metered Dose Inhaler Devices market in Japan (2021-2030)
• Table 26: Metered Dose Inhaler Devices market in India (2021-2030)
• Table 27: Metered Dose Inhaler Devices market in Australia (2021-2030)
• Table 28: Metered Dose Inhaler Devices market in South Korea (2021-2030)
• Table 29: Metered Dose Inhaler Devices market in Rest of APAC (2021-2030)
• Table 30: Metered Dose Inhaler Devices market in Rest of World (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Metered Dose Inhaler Devices market in Global (2021-2030)
• Figure 4: Metered Dose Inhaler Devices market in Global by Patient Type (2021-2030)
• Figure 5: Metered Dose Inhaler Devices market in Global by Application (2021-2030)
• Figure 6: Metered Dose Inhaler Devices market in Global by Distribution Channel (2021-2030)
• Figure 7: Metered Dose Inhaler Devices market in Global by Geography (2021-2030)
• Figure 8: Metered Dose Inhaler Devices market in North America (2021-2030)
• Figure 9: Metered Dose Inhaler Devices market in North America by Country (2021-2030)
• Figure 10: Metered Dose Inhaler Devices market in the US (2021-2030)
• Figure 11: Metered Dose Inhaler Devices market in Canada (2021-2030)
• Figure 12: Metered Dose Inhaler Devices market in Mexico (2021-2030)
• Figure 13: Metered Dose Inhaler Devices market in Europe (2021-2030)
• Figure 14: Metered Dose Inhaler Devices market in Europe by Country (2021-2030)
• Figure 15: Metered Dose Inhaler Devices market in France (2021-2030)
• Figure 16: Metered Dose Inhaler Devices market in Germany (2021-2030)
• Figure 17: Metered Dose Inhaler Devices market in the United Kingdom (2021-2030)
• Figure 18: Metered Dose Inhaler Devices market in Italy (2021-2030)
• Figure 19: Metered Dose Inhaler Devices market in Spain (2021-2030)
• Figure 20: Metered Dose Inhaler Devices market in Russia (2021-2030)
• Figure 21: Metered Dose Inhaler Devices market in Rest of Europe (2021-2030)
• Figure 22: Metered Dose Inhaler Devices market in APAC (2021-2030)
• Figure 23: Metered Dose Inhaler Devices market in APAC by Country (2021-2030)
• Figure 24: Metered Dose Inhaler Devices market in China (2021-2030)
• Figure 25: Metered Dose Inhaler Devices market in Japan (2021-2030)
• Figure 26: Metered Dose Inhaler Devices market in India (2021-2030)
• Figure 27: Metered Dose Inhaler Devices market in Australia (2021-2030)
• Figure 28: Metered Dose Inhaler Devices market in South Korea (2021-2030)
• Figure 29: Metered Dose Inhaler Devices market in Rest of APAC (2021-2030)
• Figure 30: Metered Dose Inhaler Devices market in Rest of World (2021-2030)
• Figure 31: Market Drivers
• Figure 32: Market Barriers
• Figure 33: Marker Opportunities
• Figure 34: PORTER'S Five Force Analysis

Metered Dose Inhaler Devices Market By Patient Type (Adult And Pedriatric), By Application (Chronic Obstructive Pulmonary Diseases (Copd), Asthma, Covid-19, Diabetes, And Others), By Distribution Channel (Online And Offline), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of chronic obstructive pulmonary diseases (copd) and rising prevalence in asthma

The global metered dose inhaler devices market was valued at USD 16,613 million in 2023, growing at a CAGR of 3.99% during the forecast period from 2024 to 2030 to reach USD 21,423 million by 2030. The metered dose inhaler devices market is witnessing a positive growth owing to the various factors such as increasing prevalence of COVID-19, rising prevalence of diabetes, increasing prevalence of asthma, surge in cystic fibrosis cases, surge in prevalence of Chronic Obstructive Pulmonary Diseases (COPD), rise in geriatric population and increase in technological advancements with respect to the product offerings. Therefore, the market for metered dose inhaler devices is estimated to grow during the forecast period from 2024 to 2030.

Metered Dose Inhaler Devices Market Dynamics:

The increased prevalence of diabetes is one of the key factors driving the market for metered dose inhaler devices. For instance, according to the International Diabetes Federation (IDF), IDF Diabetes Atlas Tenth edition released in the year 2023, worldwide, diabetes had affected about 537 million people of age between 20-79 years. Moreover, diabetes can be predicted to affect 643 million people worldwide by 2030 and 783 million people by 2045. Further, insulin powder is administered by metered dose inhalers to treat diabetes. As a result, the demand for metered dose inhaler devices rises due to an increase in diabetes cases, propelling the global metered dose inhaler devices market ahead over the forecast period (2024-2030).

Moreover, another key factor which is responsible for the growth of metered dose inhaler devices market is the increasing prevalence of asthma. For instance, according to the data published by World Health Organization (WHO) in the year 2023, in 2019, asthma afflicted an estimated 262 million individuals globally. Moreover, as per the data published by Asthma and Allergy Foundation of America in the year 2023, in 2019, approximately 25 million people had asthma in the United States. Thus, metered dose inhaler devices are used to treat asthma. Therefore, rising prevalence in asthma increases the demand for metered dose inhaler devices, which drives the overall metered dose inhaler devices market forward over the forecast period (2024-2030).

However, lack of awareness about metered dose inhaler devices and severe side effects associated with the devices, can hamper the global metered dose inhaler devices market growth.

The COVID-19 pandemic has positively impacted the market for metered dose inhaler devices, this can be due to the severe effects of COVID on lungs and it is estimated that people may have respiratory infections as an after effect of COVID, which surged the demand for metered dose inhaler devices among patients recovering with COVID, as well as shortness of breath as its prevalent symptom also contributed to the metered dose inhaler devices demand among COVID patients. Hence, the demand for metered dose inhaler devices will continue to rise in the forecast period from 2024-2030.

Metered Dose Inhaler Devices Market Segment Analysis:

Metered dose inhaler devices market by Patient Type (Adult and Pediatric), Application (Chronic Obstructive Pulmonary Diseases (COPD), Asthma, COVID-19, Diabetes, and Others), Distribution Channel (Online and Offline), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by application segment of metered dose inhaler devices market, Chronic Obstructive Pulmonary Diseases (COPD) are expected to share a significant revenue in the year 2023. Metered dose inhaler devices are a portable, easy-to-use device that delivers asthma medicine in aerosol form to the lungs. They may be used with a variety of COPD drugs, such as steroids including flovent hydrofluoroalkane (HFA) and a combination of steroid/bronchodilators such as Symbicort, and combination medications. Thus, these benefits associated with the metered dose inhaler devices can increase the demand of metered dose inhaler devices, which could increase the metered dose inhaler devices overall market. However, a rise in product launch associated with the metered dose inhaler devices also drives its market growth.

In October 2020, Zydus Cadila, multinational pharmaceutical company, announced the launch of Forglyn pMDI, India's first pressurized Metered Dose Inhaler (pMDI) with a combination of Long Acting Muscarinic Antagonist (LAMA) and Long Acting Beta Agonist (LABA) for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) in India.

Moreover, due to the interplay of all the factors mentioned above, results in the rising demand for metered dose inhaler devices, which in turn provide a conducive growth environment for overall metered dose inhaler devices during the market forecast of 2024-2030.

North America is expected to dominate the overall Metered Dose Inhaler Devices Market:

Among all the regions, North America is expected to dominate the global metered dose inhaler devices market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the rising prevalence of asthma and surge in cystic fibrosis cases are expected to increase the demand for metered dose inhaler devices in the North American market.

According to the data published by WHO from 3 January 2020 to 21 September 2022, there have been 94,471,064 confirmed cases of COVID-19 in United States. Further, COVID-19 increases the risk of respiratory infections in the patients affecting the lungs. Thus, rising prevalence of COVID increases the demand for metered dose inhaler devices, which surges the growth for metered dose inhaler devices overall market forecast.

Moreover, as per the latest data released by American Lung Association in the year 2020, cystic fibrosis affected approximately 30,000 people in the United States. Also, as per the cystic fibrosis Canada's 2020 annual data report from the Canadian Cystic Fibrosis Registry, released that in 2020, there were 4,332 Canadians with CF, with 62% of them being adults. Further, metered dose inhalers are available for the treatment of cystic fibrosis. Therefore, surge in cystic fibrosis cases would increase the demand for metered dose inhaler devices, which boost the metered dose inhaler devices overall market growth.

Furthermore, the factors mentioned above, provide a conducive growth environment for North American region in metered dose inhaler devices market.

Metered Dose Inhaler Devices Market Key Players:

Some of the key market players operating in the metered dose inhaler devices market include H&T Presspart Manufacturing Ltd, MidasCare, Beximco Pharmaceuticals Ltd, BioCare Group (M) Sdn Bhd, Intech Biopharm Corporation, AstraZeneca, Recipharm AB (publ), Maya Biotech Pvt. Ltd, BreatheSuite Inc, and among others.

Recent Developmental Activities in the Dry Powder Inhaler Devices:

In March 2022, Novartis' Sandoz, a Swiss multinational pharmaceutical corporation, acquired, UK based delivery device development company, Coalesce Product Development Limited, developing a portfolio of inhalation devices. This includes new versions of pressurized metered dose inhalers (pMDI), breath-actuated inhalers (BAI) and pre-metered dry powder inhalers (DPI).

In February 2022, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced the launch of HeroTracker® Sense, a unique digital respiratory health solution that turns a normal metered dosage inhaler (pMDI) into a smart linked healthcare device.

In September 2022, BreatheSuite Inc., a Canadian connected respiratory health startup, announced that its BreatheSuite Metered-Dose Inhaler (MDI) V1 device has acquired 510(K) approval from the US Food and Drug Administration (FDA). The BreatheSuite gadget converts conventional MDIs into smart inhalers by automatically and objectively monitoring and delivering feedback on inhaler adherence and technique for persons with asthma and COPD. It is approved for both prescription and over-the-counter usage.

Key Takeaways from the Metered Dose Inhaler Devices Market Report Study

• Market size analysis for current metered dose inhaler devices market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the metered dose inhaler devices market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened over the last 3 years.
• Key companies dominating the global metered dose inhaler devices
• Various opportunities are available for the other competitor in the metered dose inhaler devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current metered dose inhaler devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for metered dose inhaler devices market growth in the coming future?

Target Audience who can be benefited from this Metered Dose Inhaler Devices Market Report Study

• Metered dose inhaler devices providers
• Research organizations and consulting companies
• Dry powder inhaler devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in metered dose inhaler devices
• Various end-users who want to know more about the metered dose inhaler devices market and latest technological developments in the metered dose inhaler devices

Frequently Asked Questions for Metered Dose Inhaler Devices:

1. What are Metered Dose Inhaler Devices?

The Metered Dose Inhaler device (MDI) is a medication canister that is pressurised and held in a plastic container with a mouthpiece. When sprayed, it delivers a constant and predictable amount of medicine. It is the most widely utilized delivery method for treating asthma, COPD, and other respiratory illnesses.

2. What is the market for Global Metered Dose Inhaler Devices?

The global metered dose inhaler devices market was valued at USD 16,613 million in 2023, growing at a CAGR of 3.99% during the forecast period from 2024 to 2030 to reach USD 21,423 million by 2030.

3. What are the drivers for the Global Metered Dose Inhaler Devices market?

The metered dose inhaler devices market is witnessing a positive market growth owing to the factors such as increasing prevalence of COVID-19, rising prevalence of diabetes, increasing prevalence of asthma, surge in cystic fibrosis cases, surge in prevalence of Chronic Obstructive Pulmonary Diseases (COPD), rise in geriatric population and increase in technological advancements with respect to the product offerings.

4. Who are the key players operating in the Metered Dose Inhaler Devices market?

Some of the key market players operating in the metered dose inhaler devices market include H&T Presspart Manufacturing Ltd, MidasCare, Beximco Pharmaceuticals Ltd, BioCare Group (M) Sdn Bhd, Intech Biopharm Corporation, AstraZeneca, Recipharm AB (publ), Maya Biotech Pvt. Ltd, BreatheSuite Inc, and among others.

5. Which region has the highest share in Metered Dose Inhaler Devices market?

North America is expected to dominate the global metered dose inhaler devices market. Factors contributing to the growth of metered dose inhaler devices market in the North America region are rising prevalence of COVID-19 and surge in cystic fibrosis cases.

Table of Contents

1.Metered Dose Inhaler Devices Market Report Introduction

2. Metered Dose Inhaler Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The US
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Metered Dose Inhaler Devices Market Key Factors Analysis

• 4.1. Metered Dose Inhaler Devices Market Drivers
  • 4.1.1. Increasing Prevalence of Diabetes
  • 4.1.2. Rising Prevalence of Asthma
  • 4.1.3. Surge in Cystic Fibrosis Cases
  • 4.1.4. Rising Prevalence of COVID-19
• 4.2. Metered Dose Inhaler Devices Market Restraints And Challenges
  • 4.2.1. Lack of Awareness about Metered Dose Inhaler Devices
  • 4.2.2. Severe Side Effects Associated with the Metered Dose Inhaler
• 4.3. Metered Dose Inhaler Devices Market Opportunities
  • 4.3.1. Conversion of Metered Dose Inhaler Devices into Smart Inhalers
  • 4.3.2. Increasing Research and Development Activities in Metered Dose Inhaler Devices

5. Metered Dose Inhaler Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Metered Dose Inhaler Devices Market

7. Metered Dose Inhaler Devices Market Layout

• 7.1. By Patient Type
  • 7.1.1. Adult
  • 7.1.2. Pediatric
• 7.2. By Application
  • 7.2.1. Chronic Obstructive Pulmonary Diseases (COPD)
  • 7.2.2. Asthma
  • 7.2.3. COVID-19
  • 7.2.4. Diabetes
  • 7.2.5. Cystic Fibrosis
  • 7.2.6. Others
• 7.3. By Distribution Channel
  • 7.3.1. Online
  • 7.3.2. Offline
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.6. Russia Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.2.7. Rest of Europe Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.3.3. India Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Metered Dose Inhaler Devices Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Metered Dose Inhaler Devices Market Size in USD million (2021-2030)

8. Metered Dose Inhaler Devices Market Company and Product Profiles

• 8.1. H&T Presspart Manufacturing Ltd
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. MidasCare
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Beximco Pharmaceuticals Ltd
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. BioCare Group (M) Sdn Bhd
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Intech Biopharm Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. AstraZeneca
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Recipharm AB (publ)
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Maya Biotech Pvt. Ltd
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. BreatheSuite Inc
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us